Srs Capital Advisors, Inc. Viatris Inc Transaction History

Srs Capital Advisors, Inc.

$977 Million
Q2 2024

A detailed history of Srs Capital Advisors, Inc. transactions in Viatris Inc stock. As of the latest transaction made, Srs Capital Advisors, Inc. holds 1,301 shares of VTRS stock, worth $15,091. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,301

Previous 140 829.29%

Holding current value

$15,091

Previous $1,000 1200.0%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	BUY	$10.05 - $12.02 $11,668 - $13,955	1,161 Added 829.29%	1,301 $13,000
Q1 2024 May 14, 2024	SELL	$11.27 - $13.53 $135 - $162	-12 Reduced 7.89%	140 $1,000
Q4 2023 Feb 06, 2024	SELL	$8.77 - $10.85 $2,394 - $2,962	-273 Reduced 64.24%	152 $1,000
Q3 2023 Nov 14, 2023	BUY	$9.59 - $11.35 $38 - $45	4 Added 0.95%	425 $4,000
Q2 2023 Aug 14, 2023	BUY	$9.02 - $10.29 $27 - $30	3 Added 0.72%	421 $4,000
Q1 2023 May 16, 2023	BUY	$9.2 - $12.26 $27 - $36	3 Added 0.72%	418 $4,000
Q4 2022 Feb 24, 2023	SELL	$8.72 - $11.56 $58,005 - $76,897	-6,652 Reduced 94.13%	415 $4,000
Q3 2022 Nov 03, 2022	SELL	$8.48 - $11.13 $2,026 - $2,660	-239 Reduced 3.27%	7,067 $60,000
Q2 2022 Aug 22, 2022	BUY	$9.95 - $12.27 $776 - $957	78 Added 1.08%	7,306 $76,000
Q1 2022 May 12, 2022	BUY	$9.81 - $15.4 $29 - $46	3 Added 0.04%	7,228 $79,000
Q4 2021 Feb 08, 2022	BUY	$12.09 - $14.68 $12 - $14	1 Added 0.01%	7,225 $98,000
Q3 2021 Nov 05, 2021	BUY	$13.25 - $15.13 $18,338 - $20,939	1,384 Added 23.7%	7,224 $98,000
Q2 2021 Aug 02, 2021	BUY	$12.97 - $16.15 $59,143 - $73,644	4,560 Added 356.25%	5,840 $83,000
Q4 2020 Feb 03, 2021	BUY	$14.3 - $18.74 $18,304 - $23,987	1,280 New	1,280 $24,000

Others Institutions Holding VTRS

# of Institutions

1,098

Shares Held

970M

Call Options Held

2.63M

Put Options Held

2.15M

View Full List

About Viatris Inc

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $14.1B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

More about VTRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Srs Capital Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Srs Capital Advisors, Inc. with notifications on news.

Account

Srs Capital Advisors, Inc. Viatris Inc Transaction History